Prostate Cancer Treatment Market |Asia-Pacific region would exhibit the highest CAGR of 6.6% during 2019-2026  

According to a new report published by Allied Market Research, titled, “Prostate Cancer Treatment Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019–2026,” the global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.

 The growth of the prostate cancer treatment market is attributed to increase in prevalence of prostate cancer across the globe. Furthermore, surge in awareness programs for prostate cancer treatment, strong emerging pipeline drugs, and growth in geriatric population are some of the factors that contribute to the growth of the market

Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/2653

Prostate cancer is a type of cancer that develops into male reproductive system. Prostate cancer begins when normal cells in the prostate gland start multiplying uncontrollably. It is more prevalent in geriatric men over the age of 65 years. Risk factors for development of prostate cancer are family history, race, and old age. It can be treated by radiation therapy, surgery, chemotherapy, biological therapy, and hormone therapy. The treatment for prostate cancer can be decided on the basis of the stage of cancer. The healthcare professionals such as radiation oncologists and urologists treat prostate cancer.

Based on distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Currently, the hospital pharmacies segment accounted for the majority of market share, owing to rise in number of hospitalized prostate cancer patients, convenience offered by them, and strong presence of hospital pharmacies across the globe. The online pharmacies is the fastest growing segment, at a CAGR of 6.4% from 2019 to 2026, owing to increase in preference for online purchasing of drugs over the traditional methods, increase in awareness regarding online pharmacies, and rise in number of internet users.

Key Findings of the Study:

  • Based on drug type, the hormone therapy segment held more than one-third share in the global prostate cancer treatment market in 2018.
  • Based on distribution channel, the hospital pharmacies segment held more than half share in the global market in 2018.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.6% during the forecast period. 

North America accounted for approximately one-half of the global prostate cancer treatment market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of prostate cancer treatment products, large presence of pharmaceutical companies, well developed healthcare infrastructure, and wide availability of prostate cancer treatment drugs. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

Key Market Segments:

By Drug Type 

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

By Distribution Channel 

  • Hospitals Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

The key players profiled in this report include Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Ferring Pharmaceuticals Inc., GlaxoSmithKline Plc, Ipsen Pharma, Johnson & Johnson, and Takeda Pharmaceutical Company Ltd.

For Purchase Enquiry:  https://www.alliedmarketresearch.com/purchase-enquiry/2653

Similar Reports:

Inhaled Nitric Oxide Market

Thermoluminescent Dosimeter (TLD) Services Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Leave a comment

Your email address will not be published.